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Abstract Although fatigue is one of the most common
and disabling symptoms in patients with multiple sclerosis
(MS), its pathogenesis is still poorly understood and it is
difﬁcult to treat. The aim of the current study was to test
the assumptions of a cognitive-behavioral model that
explains fatigue and physical disability in MS patients,
by comparing this approach with a more traditional
biomedical approach. Structural equation modeling was
applied to a sample of 262 MS patients. Neither the
cognitive-behavioral, nor the biomedical model showed an
adequate ﬁt of our data. The modiﬁcation indices sup-
ported an integration of both models, which showed a
better ﬁt than those of the separate models. This ﬁnal
model, is notable for at least three features: (1) fatigue is
associated with depression and physical disability, (2)
physical disability is associated with disease severity and
fatigue-related fear and avoidance behavior, and (3) cata-
strophic interpretations about fatigue, fueled by depression,
mediated the relationship between fatigue and fatigue-
related fear and avoidance behavior. Our results suggest
that an integrated approach, including the modiﬁcation of
catastrophic thoughts about fatigue, would be beneﬁcial in
the treatment of fatigue in MS patients.
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Introduction
Multiple sclerosis (MS) is a chronic inﬂammatory demy-
elinating disease of the central nervous system with an
unknown pathogenesis and an unpredictable course. MS is
considered to be one of the most common neurological
disorders affecting young adults (Compston and Coles
2008) The clinical picture of MS is diverse and includes
physical and neuropsychiatric symptoms (Feinstein 1999).
Up to 90% of patients with MS complain of fatigue (Branas
et al. 2000). Fatigue in MS patients is more severe and
disabling compared to fatigue in healthy controls and
several other somatic populations (De Ridder et al. 2004;
Krupp 2006; Krupp et al. 1988, 1989; Penner et al. 2007;
Trojan et al. 2007), and over two-thirds of MS patients
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DOI 10.1007/s10865-010-9266-8characterize it as their most troubling symptom (Branas
et al. 2000). The pathogenesis of MS-related fatigue is still
poorly understood and treatment options are limited (Bol
et al. 2009; Kos et al. 2008). In clinical practice, fatigue is
often treated by both pharmacological and non-pharmaco-
logical interventions, such as exercise therapy and energy
conservation strategies (Kos et al. 2008). However, the
empirical evidence for effectiveness of these interventions
is limited (Pucci et al. 2007; Rietberg et al. 2005; Solari
et al. 2003; Steultjens et al. 2003).
From a traditional biomedical perspective, MS-related
fatigue is considered to be a primary symptom of MS that is
directly related to the severity of the disease. Although there
is some evidence for underlying pathophysiological mech-
anisms, including inﬂammation, demyelinisation, axonal
loss, and neuroendocrine dysregulation, these variables
appear to explain only a small part of the variance of both
MS-related fatigue and MS-related disability (Bol et al.
2009; Kos et al. 2008). More recently, a cognitive-behav-
ioralapproachhasbeenproposedwhichsuggeststhatfatigue
is not perpetuated or worsened by the severity of the disease
or associated symptoms, but by the individual’s interpreta-
tion of these symptoms (Skerrett and Moss-Morris 2006;
Van Kessel and Moss-Morris 2006). Empirical evidence for
such an approach has been found in cases of chronic fatigue
syndrome (Deary et al. 2007; Nijs et al. 2004; Silver et al.
2002), cancer survivors (Donovan et al. 2007), and chronic
pain (Arntz and Claassens 2004; Leeuw et al. 2007).
One of the key variables in recent cognitive-behavioral
approaches of symptom reporting is the way information is
interpreted. For example, catastrophic interpretations are
characterized by exaggerated negative rumination, ampli-
ﬁcation of the symptoms, and helplessness (Leeuw et al.
2007; Sullivan et al. 1995), which are all associated with
negative emotions. In particular, catastrophizing is associ-
ated with speciﬁc, symptom-related, fear which in turn in-
cites avoidance behavior and in the long term contributes to
disability (Andrea et al. 2004; Jacobsen et al. 2004; Nijs
et al. 2004; Silver et al. 2002). There is also evidence that
MS patients who catastrophize about their fatigue and who
attribute their fatigue to their illness are more likely to focus
their attention on signs of fatigue and to interpret the con-
sequences of fatigue in terms of physical damage (Skerrett
and Moss-Morris 2006). A second feature of a cognitive-
behavioral approach is its focus on functioning in the pres-
ence of persistent symptoms such as pain and fatigue. There
is evidence that the functional disability levels are more
strongly inﬂuenced by the emotional responses to the
symptoms than the symptoms themselves (e.g. Crombez
et al. 1999).
The hypothesis of the cognitive-behavioral model was
that patients who interpret their fatigue catastrophically,
report more fatigue-related fear and avoidance, and hence
are more physically disabled, depressed and fatigued
(Skerrett and Moss-Morris 2006; Van Kessel and Moss-
Morris 2006). In contrast, the biomedical model assigns a
more prominent role to disease severity and depression
in predicting the level of fatigue (Amato et al. 2001;
Janardhan and Bakshi 2002; Merkelbach et al. 2002) and
considers catastrophizing about fatigue, and fatigue-related
fear and avoidance, to be consequences rather than pre-
cursors of physical disability.
In present study we compared a model based on a
cognitive-behavioral approach with that based on a more
traditional, biomedical approach. Given the merits of both
approaches, a comparison of both approaches is not only
interesting theoretically, but may also provide elements for
a better care of patients with MS-related fatigue and dis-
ability. Using structural equation modeling (SEM), we
compared the ﬁt indices of our data according to both
theoretical models. In line with evidence in other popula-
tions (Deary et al. 2007; Donovan et al. 2007; Leeuw et al.
2007; Nijs et al. 2004; Silver et al. 2002), we expected to
ﬁnd that the cognitive-behavioral model would show a
better ﬁt than the traditional biomedical model.
The results of this study may have clinical implications.
The ﬁrst, and so far only, randomized clinical trial
of cognitive-behavioral therapy (CBT) in MS patients
appeared to be more effective in reducing self-reported
fatigue than relaxation therapy (Van Kessel et al. 2008).
Not only fatigue, but also fatigue-related disability and
depression showed a signiﬁcant decrease. These results are
in favor of a cognitive-behavioral approach to treat fatigue,
but the theoretical assumptions of CBT were not formally
tested yet. The focus of the present study is to test the
underlying mechanisms of CBT. Insight into how the
various relevant factors may affect one another, can help
us to develop more responsive interventions to treat
MS-related fatigue and disability.
Method
Participants
Participants were recruited from the hospital databases of
the Departments of Neurology of the Maastricht University
Medical Centre and Atrium Medical Centre Parkstad He-
erlen. A total of 404 patients aged 18 years and older, and
diagnosed with clinically deﬁnite MS (McDonald et al.
2001), were eligible for inclusion. To preserve patient
conﬁdentiality, the initial letters were sent to these 404 MS
patients by their treating neurologist. In total 294 patients
were willing to participate and contacted the researchers
(73% response rate) and all these 294 patients were
screened by telephone to verify eligibility. Four patients
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123were excluded because they had problems understanding
the questionnaires. Furthermore, ten patients who had
suffered from a (recent) exacerbation and were taking
corticosteroids were included 4 weeks later when their
condition was stabilized. In total 290 patients were sent a
patient information letter, a consent form and question-
naires. Only 20 patients failed to return these forms,
leaving the total sample at 270 (93% response rate). The
medical ethics committee of both the Maastricht University
Medical Centre and Atrium Medical Centre Parkstad
Heerlen approved the study and patients gave their in-
formed consent. Patients did not receive any ﬁnancial
compensation for their participation.
Measures
Basic demographic information, including age, gender,
marital status, level of education, employment status, a
history of psychiatric and somatic diseases and use of
psychopharmaca was obtained with the help of a demo-
graphic inventory ﬁlled out by the MS patients. The level
of education was assessed by classifying formal schooling
in three groups: those with at most primary education (low
level of education); those with junior vocational training
(average level of education); and those with senior voca-
tional or academic training (high level of education).
Medical data, including disease severity, disease course,
disease duration, and MS medication, were collected from
the hospital databases.
Disease severity
The Expanded Disability Status Scale (EDSS) (Kurtzke
1983), which was assessed by an experienced neurologist
familiar with EDSS recording (RH), provided a measure of
disease severity. The EDSS is divided into eight func-
tioning systems (pyramidal, cerebellar, brainstem, mental,
bowel and bladder, visual-optic, sensory, and other).
Impairment in each system is graded separately by means
of neurological examination. EDSS scores range from 0 to
10, with 0 being normal neurological examination and 10
being death due to MS. If there was no recent ([3 months)
EDSS score available, the treating neurologist was con-
sulted for a new assessment.
All participants completed the Dutch versions of the
following questionnaires:
The Abbreviated Fatigue Questionnaire (AFQ) (Alberts
et al. 1997) was used to measure physical fatigue. The AFQ
is a valid, reliable, and easy-to-use instrument (Alberts
et al. 1997), that consists of four items (‘I feel tired’, ‘I tire
easily’, ‘I feel ﬁt’ and ‘I feel physically exhausted’), which
are rated on a seven-point Likert scale with scoring alter-
natives ranging from ‘‘yes, that is true’’ to ‘‘no, that is not
true’’. After inverting the items 1, 2 and 4, a total score was
calculated (range 4–28), with higher scores indicating
higher severity of physical fatigue.
Catastrophizing about fatigue was measured with the
Fatigue Catastrophizing Scale (FCS), which is an adapted
version of the Pain Catastrophizing Scale (PCS) (Crombez
and Vlaeyen 1996; Sullivan et al. 1995). The PCS is a
13-item questionnaire that measures the frequency of ca-
tastrophizing thoughts reported by patients about the pain
they experience. Psychometric properties of the PCS ap-
peared adequate (Crombez et al. 1998; Van Damme et al.
2000). We adapted the PCS by replacing the word ‘pain’ by
the word ‘fatigue’ in all items. Scoring alternatives ranged
from ‘strongly disagree’ to ‘strongly agree’. Three MS-
related items were added (‘‘When I am tired, this is a signal
there is something wrong in my brain’’, ‘‘When I am tired,
this is a warning for physical decline’’, ‘‘When I am tired,
this is a sign that my MS is getting worse’’). The FCS
consists of 16 items, with scores ranging from 0 to 64 and
with higher scores indicating higher intensity.
The fatigue version of the Tampa Scale for Kinesiopho-
bia (TSK-F) (Silver et al. 2002) was used to measure fati-
gue-related fear and avoidance behavior. The TSK-F is an
adaptedversionoftheoriginal17-itemTSKforchronicpain
(Miller et al. 1991; Vlaeyen et al. 1995). The TSK is a valid
and reliable instrument (Vlaeyen et al. 1995; Roelofs et al.
2007),andmeasurestheextenttowhichpatientsbelievethat
pain associated with physical activity is a sign of physical
damage, and the extent towhich they avoid physical activity
because of these beliefs. To make this questionnaire ade-
quate for fatigue, the word ‘pain’ was replaced by the word
‘fatigue’andtheitemswereadjusted,e.g.,‘‘IamafraidthatI
might make my symptoms worse if I exercise’’, instead of
‘‘I’m afraid that I might injure myself if I exercise’’. Each
item is provided with a four-point Likert scale with scoring
alternatives ranging from ‘not at all’ to ‘all the time’ (with
scores ranging from 17 to 68).
Depression was measured with the subscale depression
of the Hospital Anxiety and Depression Scale (HADS)
(Zigmond and Snaith 1983). The HADS is specially
designed to screen physically ill patients for anxiety and
depression and does not include somatic symptoms. The
depression scale consists of seven items, with depression
scores ranging from 0 to 21 and with higher scores indi-
cating higher intensity. Scores over seven indicate that MS
patients are likely to be depressed (Honarmand and Fein-
stein 2009). Reliability and validity are adequate for several
clinical populations, including MS (Bjelland et al. 2002;
Honarmand and Feinstein 2009; Spinhoven et al. 1997).
The physical dimension of the Short Form Health Sur-
vey (SF-36) (Aaronson et al. 1998) was used to measure
physical disability. The physical dimension includes four
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123subscales, viz., physical functioning, role limitations due to
physical health problems, bodily pain, and general health.
The standardized scores (ranging form 0 to 100) of each
subscale were added to lower scores that indicated a higher
level of physical disability. The SF-36 was found to have
adequate psychometric properties (Aaronson et al. 1998).
Statistical analyses
Data analysis was performed using SPSS 16.0.1 for Win-
dows (SPSS Inc., Chicago, IL). Data were checked for
missing values, normality and outliers. Of the 270 returned
questionnaires, eight cases were excluded because too
many values were missing (C25% of items of question-
naire missing or C50% if a questionnaire consisted of four
items). For all other cases (n = 26) all missing values were
random and imputed by inserting the mean of the
remaining non-missing items of the subscale. Any vari-
ables that were signiﬁcantly skewed (skewness\–1 or[1)
were transformed appropriately before parametric testing.
Descriptive statistics were used to describe the sample.
Cronbach’s alpha was used to test reliability of all ques-
tionnaires. Pearson-correlations were used to analyze
relations between all variables. The models were tested and
modiﬁed with the help of the computer program AMOS
16.0.1 (Arbuckle 2007). We tested a measurement model
with directly observed variables in which the error terms
associated with the observed variables were left free to be
estimated and also were assumed to be uncorrelated with
each other. In line with the recommendations of Byrne
(2001), model ﬁt was assessed using several ﬁt indices,
viz., chi-square statistic (v
2), goodness-of-ﬁt index (GFI),
adjusted goodness-of-ﬁt index (AGFI), root mean square
error of approximation (RMSEA), comparative ﬁt index
(CFI) and the consistent akaike information criteria (CAIC)
respectively.
According to guidelines for SEM, the data were con-
sidered to ﬁt the model if the v
2, which is a statistical test of
lack of-ﬁt resulting from overidentifying restrictions placed
in a model, was not signiﬁcant. v
2 is the most frequently
used goodness-of-ﬁt index. A statistically signiﬁcant v
2
indicates that a signiﬁcant amount of observed covariance
between items remains unexplained by the model, while a
non-signiﬁcant v
2 implies a good ﬁt of the model to the
data. However, this index is sensitive to sample size, which
is a disadvantage (Schumacker and Lomax 2004). In a
small sample, a poor ﬁt may result in a non-signiﬁcant v
2,
indicating a good ﬁt. In a large sample, a good ﬁt may
result in a signiﬁcant v
2, indicating a poor ﬁt. Values of the
GFI and the AGFI that assess the extent to which a model
provides a better ﬁt compared to no model at all, should be
high, respectively, above 0.95 and 0.85. The RMSEA was
taken into account as a measure of discrepancy per degree
of freedom. RMSEA estimates lack of-ﬁt in a model
compared to a perfect model, and should therefore be
small. RMSEA values up to 0.05 indicate a close ﬁt,
whereas values ranging between 0.08 and 0.10 indicate a
mediocre ﬁt, and those greater than 0.10 indicate a poor ﬁt.
The CFI represents the proportionate improvement in
model ﬁt by comparing the target model with a baseline
model, usually a null model in which all the observed
variables are uncorrelated; CFI values larger than 0.95
indicate an adequate ﬁt. The CAIC is used to compare two
or more not-nested models, with smaller values repre-
senting a better ﬁt.
Results
Patient sample
In total 262 Caucasian outpatients (69 male, 193 female)
were included in this study. Their mean age was 47.6
years (SD = 11.7, range 21–80). Most of them (n =
136) had a relapsing remitting disease course, while 67
patients had a secondary progressive, and 59 patients a
primary progressive course. The average EDSS score
was 4.0 (SD = 2.2, range 0–8), which reﬂects a mod-
erate disease severity. See Table 1 for a summary of all
patient characteristics.
Table 2 presents means, standard deviations, ranges,
Cronbach’s alphas for all variables under study, as well as
their intercorrelations (Pearson). All questionnaires had
excellent internal consistency as measured by Cronbach’s
alpha, ranging from 0.82 to 0.91. Although all intercorre-
lations were statistically signiﬁcant (P\0.01), the stron-
gest one was found between catastrophizing about fatigue
and fatigue-related fear and avoidance behavior. Higher
levels of catastrophizing about fatigue were related to
higher levels of fatigue-related fear-avoidance behavior
(r = 0.64, P\0.001). The lowest intercorrelation was
found between disease severity and catastrophizing about
fatigue (r = 0.17, P\0.01).
Structural equation modeling analyses
An overview of all goodness-of-ﬁt indices is displayed in
Table 3. Figure 1 depicts the SEM results for the cogni-
tive-behavioral model (model 1). None of the goodness-of-
ﬁt indices satisﬁed the a priori criteria for a good model ﬁt.
Although all hypothesized relationships of the biomedical
model (model 2, Fig. 2) were statistically signiﬁcant, SEM
analyses of this model also revealed an unacceptable ﬁt. As
such, neither of the initial models that were designed
a priori ﬁtted our data.
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123Table 2 Means, standard deviations (SD), range, Cronbach’s alpha’s (a) and Pearson-correlations of all measures
Mean (SD) Range a 23456
1. Disease severity (EDSS) 4.0 (2.2) 0–8 – 0.27** 0.17* 0.25** 0.26** –0.58**
2. Fatigue (AFQ) 19.8 (6.6) 4–28 0.91 – 0.56** 0.37** 0.49** –0.60**
3. Catastrophizing about fatigue (FCS) 20.4 (15.1) 0–64 0.91 – – 0.64** 0.57** –0.57**
4. Fatigue-related fear and avoidance (TSK-F) 37.9 (9.4) 17–61 0.82 – – – 0.50** –0.56**
5. Depression (HADS-D) 6.0 (4.2) 0–21 0.83 – – – – –0.57**
6. Physical disability (SF-36) 246.3 (87.0) 15–390 0.91 – – – – –
EDSS Expanded Disability Status Scale, AFQ Abbreviated Fatigue Questionnaire, FCS Fatigue Catastrophizing Scale, TSK-F Fatigue Version
of the Tampa Scale for Kinesiophobia, HADS Hospital Anxiety and Depression Scale, SF-36 Short Form Health Survey
* P\0.01; ** P\0.001
Table 3 Goodness-of-ﬁt summary for the models tested
v
2 (df) RMSEA GFI AGFI CFI CAIC
Model 1. Cognitive-behavioral model 202.77(8)** 0.305 0.814 0.512 0.709 288.16
Model 2. Biomedical model 107.76 (7)** 0.235 0.902 0.706 0.85 199.71
Model 1a: added
Disease severity to physical disability 102.15 (7)** 0.228 0.886 0.659 0.858 194.11
Model 1b: added
Physical disability to depression 52.54 (6)** 0.172 0.94 0.789 0.931 151.06
Model 1c: added
Depression to catastrophizing 25.93 (5)** 0.127 0.969 0.87 0.969 131.02
Model 1d: added
Disease severity to fear-avoidance 14.86 (4)* 0.102 0.982 0.905 0.984 126.52
Final model (model 3): deleted
Non-signiﬁcant paths 17.44 (6)* 0.085 0.979 0.925 0.983 115.96
GFI Goodness-of-Fit Index, AGFI Adjusted Goodness-of-Fit Index, RMSEA Root Mean Square Error of Approximation, CFI Comparative Fit
Index, CAIC Consistent Akaike Information Criteria
* P\0.01; ** P\0.001
Table 1 Patient characteristics (n = 262)
Gender (% male/% female) 26/74
Age in years (mean, (SD)) 47.6 (11.7) Range 21.1–79.9
Disease duration in years (mean, (SD)) 8.6 (7.9) Range 0.1–53.7
Disease course (% RR, % SP, % PP) 52/26/22
EDSS (mean, (SD)) 4.0 (2.2) Range 0–8
HADS-depression (%\8/% C8) 68/32
Use of disease modifying drugs (% yes, % no) 43.5/56.5
Interferon (%) 18.3
Glatiramer acetate (%) 3.8
Other (%) 15.3
Use of psychopharmaca (% yes, % no) 26/74
Level of education (% low, % average, % high) 28/36/36
Marital status (% partner/% no partner) 78/22
Employment status (% working, % not working) 30/70
RR Relapsing Remitting, SP Secondary Progressive, PP Primary Progressive, EDSS Expanded Disability Status Scale, HADS Hospital Anxiety
and Depression Scale
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123Although SEM is generally used to test pre-speciﬁed
conceptual models, it is often also applied in an exploratory
way (Arbuckle 2007). Since there is empirical support for
both cognitive-behavioral and biomedical factors in
explaining MS-related fatigue, it was anticipated that the
exploratory use of SEM, including factors of both models,
would improve the overall understanding of fatigue and
physical disability in MS. To explore whether a better ﬁt-
ting model existed, we adapted the cognitive-behavioral
model by adding relationships suggested by the modiﬁca-
tion indices provided by the AMOS program (Byrne 2001;
Schumacker and Lomax 2004). A modiﬁcation index (MI)
represents the value that v
2 is expected to decrease if such a
relationship would be included. In this way new causal
relationships that improve the model can be identiﬁed.
Because SEM is a theoretically driven technique, we only
added theoretically meaningful modiﬁcations. We subse-
quently added the relationships between disease severity
and physical disability (MI = 80.10); physical disability
and depression (MI = 33.77); depression and catastro-
phizing about fatigue (MI = 12.97); and disease severity
and fatigue-related fear and avoidance behavior (MI =
10.56). Finally, we successively deleted non-signiﬁcant
relationships in order to explain as much variance as pos-
sible with a minimum of variables (principle of maximum
parsimony). We deleted two non-signiﬁcant relationships,
respectively, the path from disease severity to fatigue, and
from fatigue-related fear and avoidance behavior to
depression, and subsequently reﬁtted each model. Although
the RMSEA still showed a mediocre ﬁt and the v
2 was still
signiﬁcant, the ﬁnal model (see Table 3 and Fig. 3) pro-
duced the lowest CAIC value, indicating the best ﬁt of all
the models proposed.
Discussion
The aim of the current study was to test the assumptions of
a cognitive-behavioral model by comparing these with
those of a traditional biomedical model. In particular, we
tested and explored the role of catastrophic (mis)interpre-
tations on MS-related fatigue and physical disability. In
contrast to the biomedical model, the cognitive-behavioral
model’s main assumption is that fatigue is not perpetuated
or worsened by disease severity or associated symptoms,
but by the patient’s interpretation of these symptoms.
SEM revealed that neither of these models showed
adequate ﬁt of our data and the modiﬁcation indices sug-
gested an integrative approach. As such, the cognitive-
behavioral model was subsequently modiﬁed by adding
several theoretically meaningful relationships derived from
Disease severity
Physical Disability Depression
Fatigue
Catastrophizing
Fear-Avoidance
-.03
.17*
.43**
.55**
-.47**
.43**
-.45**
(.24)
(.40)
(.29)
(.30)
(.37)
Fig. 1 Cognitive-behavioral model. Fear-Avoidance Fatigue-related
fear and avoidance behavior, Catastrophizing catastrophizing about
fatigue. Values shown are standardized regression coefﬁcients.
Explained variances are provided in parentheses. * p\.01;
** p\.0.001
Disease severity 
Physical Disability Depression
Fatigue
Catastrophizing
Fear-Avoidance
.64**
.56**
-.41**
.26**
.45**
-.34**
0.16*
-.30**
(.07)
(.31)
(.26)
(.61)
(.41)
Fig. 2 Biomedical model. Fear-Avoidance Fatigue-related fear and
avoidance behavior, Catastrophizing catastrophizing about fatigue.
Values shown are standardized regression coefﬁcients. Explained
variances are provided in parentheses. * p\.01; ** p\.0.001
Disease severity
Physical Disability Depression
Fatigue
Catastrophizing
Fear-Avoidance
-.50** .16*
-.33**
.54**
-.52**
-.44**
.22**
.36**
.33**
(.33)
(.39)
(.51)
(.43)
(.43)
Fig. 3 Final model. Fear-Avoidance Fatigue-related fear and avoid-
ance behavior, catastrophizing catastrophizing about fatigue. Values
shown are standardized regression coefﬁcients. Explained variances
are provided in parentheses. * p\.01; ** p\.0.001
360 J Behav Med (2010) 33:355–363
123the biomedical approach and deleting non-signiﬁcant
relationships. Although, the ﬁnal model did not meet all
preset ﬁt criteria, it showed the best ﬁt indices. The sub-
optimal ﬁt of the ﬁnal model could be due to the omitted-
variable problem, which means that we failed to have in-
cluded other relevant variables such as sleep problems,
disease course, and medication use. Inclusion of such
variables in future work may improve the ﬁt indices. Even
though some relevant variables may be lacking in the ﬁnal
model, its present structure is generally in line with that of
the fear-avoidance model of chronic pain (Vlaeyen and
Linton 2000; Leeuw et al. 2007) and with evidence for the
joint contribution of biomedical and psychological factors
in the prediction of pain and disability (Peters et al. 2005).
The integrated model is notable for at least three main
features: ﬁrst, fatigue is associated with depression and
physical disability. Second, physical disability is associated
with disease severity and fatigue-related fear and avoid-
ance behavior, and third, catastrophic interpretations about
fatigue, -fueled by depression-, mediate the relationship
between fatigue and fatigue-related fear and avoidance
behavior.
Catastrophic interpretations of fatigue such as ‘‘When I
am tired, this is a signal there is something wrong in my
brain’’ and ‘‘When I am tired, this is a sign that my MS is
getting worse’’ seemed to be a key factor and mediated the
relationship between fatigue and fatigue-related fear and
avoidance behavior. Hence, catastrophizing about fatigue
may be an important target for cognitive-behavioral inter-
ventions during which dysfunctional fatigue-related
thoughts can be challenged (e.g. Swain 2000). In this kind
of cognitive treatment, patients are given the opportunity to
test the credibility of their beliefs in catastrophic outcomes,
and to correct these accordingly.
Furthermore, depression appeared to play an important
role in our ﬁnal model. Depression was a negative conse-
quence of increased disability, and it directly contributed to
fatigue and catastrophizing about fatigue. Depression is
known to be the most common psychiatric disorder in MS,
with an estimated prevalence ranging between 27 and 54%
(Minden et al. 1987; Minden and Schiffer 1990; Sadovnick
et al. 1996; Schiffer et al. 1983). Therefore, we recommend
the inclusion of depression in screening procedures and
treatment for fatigued MS patients.
In contrast to the fear-avoidance model in chronic pain,
disease severity played a prominent role in our ﬁnal model.
Disease severity indirectly contributed to fatigue, through
fatigue-related fear and avoidance behavior, and physical
disability. MS patients with higher levels of disease
severity seem to experience more fear-related cognitions,
and hence more physical disability. One of the reasons why
disease severity in MS has a prominent role in prediction of
fatigue and disability may be that the disease and the dis-
ease-related symptoms of MS are much less ambiguous as
compared other chronic illness conditions such as in
patients with chronic pain and chronic fatigue syndrome.
While our results are in line with those of the ﬁrst ran-
domized clinical trial of cognitive-behavioral therapy
(CBT) for fatigue in MS patients (Van Kessel et al. 2008),
they also suggest that optimal treatment could be a com-
bination of CBT and medical therapy. Given that most MS
patients already receive medical treatment, more efforts
should be directed towards the cognitive and behavioral
aspects of fatigue. Since the CBT trial from Van Kessel e.a
(2008), was rather non-speciﬁc and focusing—in only one
session—on changing negative thoughts, our ﬁndings
suggests that its effectiveness might be increased by better
tailored CBT. Fatigued MS patients could beneﬁt more if
the target of CBT is on challenging idiosyncratic catas-
trophizing thoughts about fatigue and not negative thoughts
in general. Such a treatment would be similar to exposure-
based interventions for patients who report increasing pain-
related fear (e.g. De Jong et al. 2005; Bailey et al. 2010).
There are several limitations to this study, which should
be taken into account when interpreting the results and
which may be addressed in future studies. First of all, the
design is cross-sectional, making it impossible to draw ﬁrm
conclusions about causal relationships between variables.
Prospective and longitudinal studies are warranted to
conﬁrm causality. Secondly, because of our relatively
small sample size, we were not able to split our sample in
order to cross-validate our ﬁnal model. Thirdly, we used
postal questionnaires to collect our data. Although we had
a favorable response rate for a postal questionnaire, we
were not able to examine the differences between
responders and non-responders. As a result, we cannot
exclude the fact that a potential selection bias might have
interfered with the present results. Fourthly, our measures
for catastrophizing about fatigue (FCS), and fatigue-related
fear and avoidance behavior (TSK-F), are adaptations of
valid instruments. Although both measures show excellent
internal consistency, their reliability and validity need to be
established further. Finally, all data, including those on
physical disability, were self-reported and therefore ame-
nable to retrospective bias and social desirability effects.
Furthermore, it is possible that strong associations between
self-reported variables are the result of shared-method
variance (Podsakoff et al. 2003). Future studies should also
include more objective measures such as an accelerometer,
which is a reliable and valid measure of daily activity
levels (Bassett 2000; Ng and Kent-Braun 1997).
Despite the limitations described above, this study
shows that not only severity of disease, but also cognitive-
behavioral factors, such as catastrophizing about fatigue
and fatigue-related fear and avoidance behavior, have to be
considered when trying to explain fatigue and physical
J Behav Med (2010) 33:355–363 361
123disability in MS patients. As such our results suggest that
an integrated approach, would be beneﬁcial in the treat-
ment of fatigue in MS patients.
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